logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
16/09/2025
Newly added Hong Kong stock connect targets saw a decrease in gains: Pharmaron-B up 22%, Mirxes-B up 12%, Baize Medical up 46%.
Latest
1 m ago
Jichuan Pharmaceutical (600566.SH) Subsidiary Obtains Registration Certificate for Lidocaine Gel Patch Medicinal Product
1 m ago
Zhao Bangji Life (01660) plans to change its name to "Seven Element Investment Holdings Limited"
2 m ago
Wanneng Electric Power's controlling shareholder and concerted action person have completed an increase in holdings, with an amount close to 1.5 billion.
2 m ago
Huagong Technology: The annual production capacity plan for optical communication modules is to reach 1 million units per month within the year.
2 m ago
In 2024, CIETAC accepted 758 international cases, an increase of 18% compared to the previous year.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.